Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Antioxidants (Basel, Switzerland)|July 26, 2020
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, et al.
Antioxidants & Redox Signaling|April 12, 2017
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational OverviewCarlo Gabriele Tocchetti, Christian Cadeddu, Daniela Di Lisi, et al.
Biomolecules|February 24, 2024
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and BeyondUmberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Antioxidants & Redox Signaling|August 23, 2019
What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients?Valentina Mercurio, Alessandra Cuomo, Roberta Della Pepa, et al.
Heart Failure Reviews|July 1, 2019
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogensChristian Cadeddu Dessalvi, Alessia Pepe, Claudia Penna, et al.
Heart Failure Reviews|February 7, 2020
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinibGrazia Casavecchia, Maurizio Galderisi, Giuseppina Novo, et al.
International Journal of Cardiology|May 15, 2015
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of CardiologyRosalinda Madonna, Christian Cadeddu, Martino Deidda, et al.
European Heart Journal. Cardiovascular Imaging|January 12, 2021
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)Concetta Zito, Roberta Manganaro, Maurizio Cusmà Piccione, et al.
Therapeutic Advances in Cardiovascular Disease|November 29, 2024
Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort studyAlberto Palazzuoli, Filippo Pirrotta, Alessandra Cartocci, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 21, 2023
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samplesErberto Carluccio, Frank L Dini, Michele Correale, et al.
Pageof 10